BioSpace News Archive

CSA Medical Inc. announced that it has secured $23 million in venture debt and equity financing to advance its two novel cryospray therapy platforms, truFreeze and Rejuvenair.

New analyses results reinforce effectiveness and safety for the use of TRULANCE in adults with CIC or IBS-C

David Sinclair, PhD, co-founder and chairman of Life Biosciences Inc., has been appointed an Officer of the Order of Australia “for distinguished service of a high degree to Australia and humanity at large.”

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that FAREVA has selected TraceLink’s serialization solutions to ensure compliance with the EU Falsified Medicines Directive (FMD).

Presentations Highlight Data of YUPELRI Compared with Tiotropium in Subpopulation of COPD Patients with Suboptimal Peak Inspiratory Flow Rates, Report Additional Data from Pivotal Phase 3 Program in Patients with Moderate to Very Severe COPD

Digital health company delivers mobile depth imaging with submillimeter resolution and no need for specialty hardware.

Phase 3 TIMES 1, TIMES 2 and TIMES 3 trials for Imeglimin are now fully enrolled with over 1,100 patients

Collaborative effort will accelerate development of novel therapies for underserved diseases involving the central nervous system

DaVita Hospital Services continues to deliver on quality with second reaccreditation

13 patients with serious and life-threatening S. aureus infections were treated with AB-SA01 at the Westmead Hospital in Sydney under AmpliPhi’s expanded access program